PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 1, 1989Pacing and Clinical Electrophysiology118 citations

Pacemaker‐Induced Superior Vena Cava Syndrome: Report of Four Cases and Review of the Literature

View Full Paper
JGJohn GoudevenosPRPeter ReidPAPhilip C. Adams

Key Result

Local infection and severed retained leads are important predisposing factors for pacemaker-induced superior vena cava syndrome, which is treatable with apparatus removal and anticoagulation.

Study Design

Type

Case Report (n=4)

Structured PICO

P
Population
Four cases of superior vena cava syndrome due to transvenous pacing leads, along with a review of over 30 previously reported cases.
E
Exposure
Management of pacemaker-induced superior vena cava syndrome (removal of infected apparatus, anticoagulation, thrombolytic therapy, angioplasty, or surgical relief)
O
Outcome
Clinical improvement and resolution of obstruction

Local infection and severed retained leads are key predisposing factors for pacemaker-induced superior vena cava syndrome, which can be managed with apparatus removal, anticoagulation, and thrombolysis.

Abstract

Superior vena cava syndrome due to transvenous pacing leads is a rare event. We describe four cases. One occurred among 3,100 primary pacemaker insertions performed at our institution. In the other three cases the primary insertion had been performed elsewhere. Over 30 cases have been reported previously. Local infection, which preceded the development of superior vena cava syndrome in each of our four cases, and the presence of a severed retained lead, as in three of our cases, are important predisposing factors. There is no strong evidence that multiple lead insertion, if each lead remains intact, significantly increases the risk. The pathology at the site of obstruction includes thrombosis and in some cases fibrotic narrowing. Venous angiography is useful to show the site of obstruction, the extent of collateral circulation and to assess the response to treatment. Treatment should include removal of any infected pacemaker apparatus, anticoagulation and, if symptoms are of recent onset, thrombolytic therapy. Most patients improve but in those who do not angioplasty or surgical relief of the obstruction may be helpful.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Goudevenos et al. (1989) conducted a case report in Pacemaker-Induced Superior Vena Cava Syndrome (n=4). Transvenous pacing leads was evaluated on Development of superior vena cava syndrome. Local infection and severed retained leads are important predisposing factors for pacemaker-induced superior vena cava syndrome, which is treatable with apparatus removal and anticoagulation.

synapsesocial.com/papers/6a612709a47b29a8623f6634https://doi.org/10.1111/j.1540-8159.1989.tb01881.x
Ask AI
Helpful
Bookmark
Share
View Full Paper